Head-to-head · Cost-Efficiency Index
Maximus vs Revive Longevity
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Maximus
People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account.
Visit MaximusRevive Longevity
Shoppers who want compounded tirzepatide from a program that names its pharmacy, and who don't need semaglutide.
Visit Revive LongevityThe verdict
Maximus and Revive Longevity tie on the Cost-Efficiency Index at 73/100, so neither wins outright on the numbers, so choose on fit. Maximus: People who want compounded tirzepatide at a flat price across doses and are willing to prepay at least two months, or who want brand-name pens and tablets in the same account. Revive Longevity: Shoppers who want compounded tirzepatide from a program that names its pharmacy, and who don't need semaglutide.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs Maximus.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Maximus | Revive Longevity |
|---|---|---|
| Cost-Efficiency Index | 73/100 | 73/100 |
| Semaglutide / mo | Not offered | Not offered |
| Tirzepatide / mo | $249.99/mo2-month plan, billed up front, compounded | $279Every 4 weeks (compounded, subscription you can cancel; $299 for a single month) |
| Semaglutide / yr (modeled) | — | — |
| Tirzepatide / yr (modeled) | $2,988 | $3,62713 charges |
| Coverage | 47 states | All 50 states |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #92 | #93 |
Maximus
73/100Where the value is
- Its pricing FAQ lists every plan length: $249.99 a month on 2 months, $219.99 on 4, $199.99 on 6 and $149.99 on 12, with no separate first-month price
- One flat rate covers every dose tier, with no membership fee and free shipping
- Also offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro pens plus the Wegovy and Foundayo tablets
The tradeoffs
- There is no month-to-month tirzepatide plan: the shortest is two months, billed up front, and plans renew automatically at the same term
- No compounded semaglutide option
Regulatory note: the FDA issued a warning letter to Maximus Health, Inc. dba Maximus in June 2026. We still list and link to Maximus; you should know the letter is on the public record before you decide.
Revive Longevity
73/100Where the value is
- Tirzepatide prices are on the product page before any questionnaire: $279 every four weeks on subscription, $299 for one month, or $749 for a three-month supply
- Names its compounding pharmacy, Strive Pharmacy in Gilbert, Arizona, and its clinical platform partner, Telegra MD
- Your card is only authorized at checkout, and the hold is released with no charge if a provider decides you aren't a candidate
The tradeoffs
- No semaglutide: tirzepatide is the only GLP-1 it sells
- The subscription bills every four weeks, which is 13 charges a year, or $3,627 at $279
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.